Hepatic arterial and portal venous complications after adult and pediatric living donor liver transplantation, risk factors, management and outcome (A retrospective cohort study)

被引:28
|
作者
Gad, Emad Hamdy [1 ]
Abdelsamee, Mohammed Alsayed [2 ]
Kamel, Yasmin [3 ]
机构
[1] Menoufiya Univ, Natl Liver Inst, Hepatobiliary Surg & Liver Transplantat, Shebein Elkoum, Egypt
[2] Menoufiya Univ, Natl Liver Inst, Radiol, Shebein Elkoum, Egypt
[3] Menoufiya Univ, Natl Liver Inst, Anaesthesia, Shebein Elkoum, Egypt
来源
关键词
Living donor liver transplantation; Hepatic artery complications; Portal vein complications; Survival;
D O I
10.1016/j.amsu.2016.04.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Hepatic arterial (HA) and portal venous (PV) complications of recipients after living donor liver transplantation(LDLT) result in patient loss. The aim of this study was to analyze these complications. Methods: We retrospectively analyzed HA and/or PV complications in 213 of 222 recipients underwent LDLT in our centre. The overall male/female and adult/pediatric ratios were 183/30 and 186/27 respectively. Results: The overall incidence of HA and/or PV complications was 19.7% (n = 42), while adult and pediatric complications were 18.3% (n = 39) and 1.4% (n = 3) respectively. However early (< 1 month) and late (> 1 month) complications were 9.4% (n = 20) and 10.3% (n = 22) respectively. Individually HA problems (HA stenosis, HA thrombosis, injury and arterial steal syndrome) 15% (n = 32), PV problems (PV thrombosis and PV stenosis) 2.8% (n = 6) and simultaneous HA and PV problems 1.9% (n = 4). 40/42 of complications were managed by angiography (n = 18), surgery (n = 10) or medically (Anticoagulant and/or thrombolytic) (n = 12) where successful treatment occurred in 18 patients. 13/42 (31%) of patients died as a direct result of these complications. Preoperative PVT was significant predictor of these complications in univariate analysis. The 6-month, 1-, 3-, 5-7-and 10-year survival rates in patients were 65.3%, 61.5%, 55.9%, 55.4%, 54.5% and 54.5% respectively. Conclusion: HA and/or PV complications specially early ones lead to significant poor outcome after LDLT, so proper dealing with the risk factors like pre LT PVT (I. e. More intensive anticoagulation therapy) and the effective management of these complications are mandatory for improving outcome. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
引用
收藏
页码:28 / 39
页数:12
相关论文
共 50 条
  • [21] Liver Regeneration After Living Donor Transplantation: Adult-to-Adult Living Donor Liver Transplantation Cohort Study
    Olthoff, Kim M.
    Emond, Jean C.
    Shearon, Tempie H.
    Everson, Greg
    Baker, Talia B.
    Fisher, Robert A.
    Freise, Chris E.
    Gillespie, Brenda W.
    Everhart, James E.
    LIVER TRANSPLANTATION, 2015, 21 (01) : 79 - 88
  • [22] Biliary strictures after pediatric living donor liver transplantation - analysis of incidence, risk factors, management and outcome
    Ciopinski, M.
    Szymczak, M.
    Stefanowicz, M.
    Kowalski, A.
    Broniszczak-Czyszek, D.
    Armata, M.
    Klaudel-Dreszler, M.
    Ski, P. Kalici.
    TRANSPLANTATION, 2023, 107 (09) : 237 - 237
  • [23] Adult to pediatric living donor liver transplantation for portal cavernoma
    Zhang, Mingman
    Guo, Chunbao
    Pu, Conglun
    Ren, Zhimei
    Li, Yingcun
    Kang, Quan
    Jin, Xianqing
    Yan, Lvnan
    HEPATOLOGY RESEARCH, 2009, 39 (09) : 888 - 897
  • [24] Risk Factors and Management for Biliary Complications Following Adult Living-Donor Liver Transplantation
    Nakamura, Tsukasa
    Iida, Taku
    Ushigome, Hidetaka
    Osaka, Masafumi
    Masuda, Koji
    Matsuyama, Takehisa
    Harada, Shumpei
    Nobori, Shuji
    Yoshimura, Norio
    ANNALS OF TRANSPLANTATION, 2017, 22 : 665 - 670
  • [25] Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: A report from the adult-to-adult living donor liver transplantation cohort study consortium
    Zimmerman, Michael A.
    Baker, Talia
    Goodrich, Nathan P.
    Freise, Chris
    Hong, Johnny C.
    Kumer, Sean
    Abt, Peter
    Cotterell, Adrian H.
    Samstein, Benjamin
    Everhart, James E.
    Merion, Robert M.
    LIVER TRANSPLANTATION, 2013, 19 (03) : 259 - 267
  • [26] Living donor liver transplantation and management of portal venous pressure
    Busani, S.
    Marconi, G.
    Schiavon, L.
    Rinaldi, L.
    Del Buono, M.
    Masetti, M.
    Girardis, M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) : 1074 - 1075
  • [27] Management of Portal Venous Complications After Liver Transplantation
    Woo, David H.
    LaBerge, Jeanne M.
    Gordon, Roy L.
    Wilson, Mark W.
    Kerlan, Robert K., Jr.
    TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY, 2007, 10 (03) : 233 - 239
  • [28] Management of Hepatic Venous obstruction after Pediatric Living Donor Liver Transplantation at Liver Transplantation Institute of Inonu University.
    Yilmaz, Mehmet
    Ozdemir, Fatih
    Koc, Suleyman
    Kutlu, Ramazan
    Ince, Volkan
    Isik, Burak
    Ara, Cengiz
    Yilmaz, Sezai
    LIVER TRANSPLANTATION, 2014, 20 : S297 - S297
  • [29] Portal Vein Complications after Living Donor Liver Transplantation
    Mita, A.
    Ikegami, T.
    Masuda, Y.
    Ohno, Y.
    Urata, K.
    Nakazawa, Y.
    Terada, M.
    Miyagawa, S. -I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 333 - 334
  • [30] The Optimal Timing and Treatment for Hepatic Arterial Complications after Living Donor Liver Transplantation
    Kinoshita, Ayaka
    Takatsuki, Mitsuhisa
    Soyama, Akihiko
    Hara, Takanobu
    Muraoka, Izumi
    Tanaka, Takayuki
    Yamaguchi, Izumi
    Adachi, Tomohiko
    Kuroki, Tamotsu
    Eguchi, Susumu
    LIVER TRANSPLANTATION, 2012, 18 : S282 - S283